Skip to main content
Premium Trial:

Request an Annual Quote

Lion Files First Patent Application for Lead Compounds

NEW YORK, Aug. 16 – Bioinformatics company Lion Bioscience of Heidelberg, Germany, said Thursday it had filed for patent protection for a series of lead compounds it had developed.  

The announcement marks Lion’s first such application and comes just 16 months after the company launched its drug discovery efforts.

“This exciting result confirms the acceleration that can be achieved by applying integrated IT-solutions in research for drug discovery,” Lion said in a statement.

“The tight integration of information driven biological research, assay development, computational chemistry, with advanced combinatorial chemistry yielded a significant improvement throughout the entire process from gene to lead," the company added.

Lion said that the compounds are designed to work against an undisclosed nuclear receptor and are derived from Lion’s proprietary chemical libraries and in house research. Lion said the compounds could potentially be used as therapeutics for metabolic and endocrine disorders.

The company said it would aim to license its drug candidates to pharmaceutical houses wishing to further develop the compounds.

Lion uses computational chemistry algorithms to select compounds with high probabilities for binding to targets of interest. In December, Lion acquired chemistry company Trega Biosciences.  

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.